Arterial stiffness and blood pressure improvement in aldosterone-producing adenoma harboring  KCNJ5  mutations after adrenalectomy

Chia-Hui Chang; Ya-Hui Hu; Yao-Chou Tsai; Che-Hsiung Wu; Shuo-Meng Wang; Lian-Yu Lin; Yen-Hung Lin; Fumitoshi Satoh; Kwan-Dun Wu; Vin-Cent Wu

doi:10.18632/oncotarget.16269

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Arterial stiffness and blood pressure improvement in aldosterone-producing adenoma harboring KCNJ5 mutations after adrenalectomy

Chia-Hui Chang, Ya-Hui Hu, Yao-Chou Tsai, Che-Hsiung Wu, Shuo-Meng Wang, Lian-Yu Lin, Yen-Hung Lin, Fumitoshi Satoh, Kwan-Dun Wu and Vin-Cent Wu _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:29984-29995. https://doi.org/10.18632/oncotarget.16269

Metrics: PDF 1779 views | HTML 2468 views | ?

Abstract

Chia-Hui Chang1,2, Ya-Hui Hu1, Yao-Chou Tsai3, Che-Hsiung Wu4, Shuo-Meng Wang5, Lian-Yu Lin6, Yen-Hung Lin6, Fumitoshi Satoh7, Kwan-Dun Wu8, Vin-Cent Wu8,9

1Division of Endocrinology and Metabolism, Department of Internal Medicine, Taipei Tzu Chi Hospital, The Buddhist Medical Foundation, Hualien, Taiwan

2Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan

3Division of Urology, Department of Surgery, Taipei Tzu Chi Hospital, The Buddhist Medical Foundation, Hualien, Taiwan

4Division of Nephrology, Department of Internal Medicine, Taipei Tzu Chi Hospital, The Buddhist Medical Foundation, Hualien, Taiwan

5Division of Urology, Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan

6Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

7Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University, Graduate School of Medicine, Sendai, Japan

8Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

9TAIPAI, Taiwan Primary Aldosteronism Investigation (TAIPAI) Study Group, Taiwan

Correspondence to:

Vin-Cent Wu, email: [email protected]

Keywords: KCNJ5 gene, arterial stiffness, PWV, TAIPAI, CAKS

Received: August 24, 2016 Accepted: March 09, 2017 Published: March 16, 2017

ABSTRACT

The aim of this study was to show the effect of KCNJ5 mutational status on arterial stiffness in aldosterone-producing adenomas after adrenalectomy. Between February 2008 and January 2010, we prospectively enrolled 108 aldosterone-producing adenoma patients undergoing adrenalectomy. We conducted repeated measurements of pulse wave velocity at baseline, 6 months, and 12 months after adrenalectomy, grouped by KCNJ5 mutational status. Prognostic factors of arterial stiffness and risk for hypertension at 12 months after adrenalectomy were analyzed after propensity score matching in a 1:1 ratio. After matching for age, sex and body mass index, 88 patients were divided equally into KCNJ5-mutant and non-mutant groups. KCNJ5 mutational status was not an independent variable in either the generalized estimating equation model (p = 0.147) or the percentage change of brachial-ankle pulse wave velocity (p = 0.106). The generalized additive model smoothing plot showed that aldosterone-producing adenoma patients who carried the KCNJ5 mutation and were aged between 37 and 60 may have a hypertension recovery advantage. According to our observations during a 12-month follow-up after adrenalectomy, KCNJ5 mutational status was not associated with improvement in arterial stiffness.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 16269

Publication Alerts

Research Papers:

Arterial stiffness and blood pressure improvement in aldosterone-producing adenoma harboring KCNJ5 mutations after adrenalectomy

Abstract